NPR3
Basic information
Region (hg38): 5:32689070-32791724
Previous symbols: [ "NPRC", "ANPRC", "C5orf23" ]
Links
Phenotypes
GenCC
Source:
- Boudin-Mortier syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Boudin-Mortier syndrome | AD | Cardiovascular | The condition has been reported as including progressive dilation of the aortic root in some individuals, and awareness may allow surveillance and potential early management | Cardiovascular; Musculoskeletal | 30032985 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPR3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 44 | 50 | ||||
missense | 67 | 73 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 7 | 1 | 9 | ||
non coding | 18 | 23 | 41 | |||
Total | 1 | 2 | 73 | 65 | 29 |
Variants in NPR3
This is a list of pathogenic ClinVar variants found in the NPR3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-32710655-G-A | NPR3-related disorder | Benign (Jul 30, 2019) | ||
5-32710680-G-A | NPR3-related disorder | Benign (Mar 20, 2019) | ||
5-32711527-C-A | Benign (May 14, 2021) | |||
5-32711547-A-ACTTTTT | Benign (May 13, 2021) | |||
5-32711571-T-TC | Benign (May 14, 2021) | |||
5-32711576-T-TTTTTA | Benign (May 14, 2021) | |||
5-32711771-G-C | NPR3-related disorder | Benign (May 06, 2021) | ||
5-32711784-C-G | Uncertain significance (Dec 01, 2021) | |||
5-32711806-C-G | Likely benign (Nov 13, 2023) | |||
5-32711806-C-T | Likely benign (Jan 29, 2024) | |||
5-32711809-G-A | Likely benign (Aug 15, 2022) | |||
5-32711819-C-G | Inborn genetic diseases | Uncertain significance (Nov 09, 2021) | ||
5-32711827-G-C | Uncertain significance (Oct 18, 2022) | |||
5-32711830-G-T | Likely benign (Dec 06, 2022) | |||
5-32711833-G-C | Uncertain significance (Dec 06, 2022) | |||
5-32711839-C-G | Likely benign (Apr 07, 2022) | |||
5-32711840-G-A | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
5-32711848-C-A | Likely benign (Oct 05, 2023) | |||
5-32711848-C-T | Likely benign (Nov 10, 2023) | |||
5-32711851-TGGCGGTGGCGTTGGCGGCGGC-T | Uncertain significance (Jun 30, 2022) | |||
5-32711863-T-TGGC | Uncertain significance (Dec 28, 2021) | |||
5-32711867-G-A | Uncertain significance (Sep 07, 2022) | |||
5-32711877-G-A | Uncertain significance (Jul 21, 2022) | |||
5-32711884-G-A | Uncertain significance (Nov 23, 2021) | |||
5-32711902-C-G | Likely benign (Aug 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPR3 | protein_coding | protein_coding | ENST00000265074 | 8 | 102644 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000101 | 0.987 | 124963 | 0 | 25 | 124988 | 0.000100 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.808 | 261 | 300 | 0.869 | 0.0000150 | 3489 |
Missense in Polyphen | 87 | 112.94 | 0.77035 | 1246 | ||
Synonymous | 0.491 | 118 | 125 | 0.944 | 0.00000665 | 1099 |
Loss of Function | 2.23 | 12 | 23.7 | 0.506 | 0.00000134 | 268 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000147 | 0.000147 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000465 | 0.0000464 |
European (Non-Finnish) | 0.000117 | 0.000115 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000134 | 0.000131 |
Other | 0.000331 | 0.000329 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity. {ECO:0000250|UniProtKB:P70180}.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.534
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.751
- hipred
- Y
- hipred_score
- 0.623
- ghis
- 0.483
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.432
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npr3
- Phenotype
- immune system phenotype; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- npr3
- Affected structure
- heart
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- skeletal system development;osteoclast proliferation;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;phospholipase C-activating G protein-coupled receptor signaling pathway;regulation of blood pressure;pancreatic juice secretion;regulation of osteoblast proliferation;positive regulation of urine volume;phosphatidylinositol-mediated signaling;negative regulation of smooth muscle cell proliferation;positive regulation of nitric-oxide synthase activity;negative regulation of cold-induced thermogenesis
- Cellular component
- integral component of plasma membrane;protein-containing complex;extracellular exosome
- Molecular function
- protein binding;G protein-coupled peptide receptor activity;natriuretic peptide receptor activity;peptide hormone binding;chloride ion binding;peptide binding;hormone binding;protein homodimerization activity